Identification and hypotensive activity of proadrenomedullin N‐terminal 20 peptide (PAMP)

Authors:
  • KKKenji Kangawa
    Kenji Kangawa
  • YIYuichiro Ishiyama
    Yuichiro Ishiyama
  • HWHisanori Washimine
    Hisanori Washimine
  • YIYoshinari Ichiki
    Yoshinari Ichiki
  • MKMari Kawamoto
    Mari Kawamoto
  • NMNaoto Minamino
    Naoto Minamino
  • HMHisayuki Matsuo
    Hisayuki Matsuo
  • TETanenao Eto
    Tanenao Eto

Abstract
Proadrenomedullin N‐terminal 20 peptide (PAMP) is a candidate for a novel biologically active peptide processed from an adrenomedullin precursor. Using a radioimmunoassay for human PAMP, major and minor immunoreactive PAMPs were purified from porcine adrenal medulla and complete amino acid sequences were determined. The major immunoreactive peptide was PAMP itself with an amidated carboxy terminus. The minor one was determined to be PAMP[5–20]. An intravenous bolus injection of human PAMP in anesthetized rats caused a rapid and strong hypotensive effect in a dose dependent manner. The present data indicate that PAMP is an endogenous biologically active peptide which is processed from adrenomedullin precursor.

This publication has 6 references indexed in Scilit: